Chief Executive Officer
Ken Reali was appointed CEO of Bioventus in April 2020. Prior to that, Reali served as President and CEO of Clinical Innovations, a medical device company focused in woman’s healthcare, from June 2015 until its successful sale in Q1 of 2020.
During his twenty-nine-year medical device career, he has gained significant experience in product development, global marketing, business development, commercialization and sales of medical devices. He has a strong background in ethics and compliance, market analysis, reimbursement strategy, regulatory and clinical affairs, new product development, sales force optimization and domestic and international product commercialization.
As a CEO, Reali has gained experience working with medical societies, patient advocacy groups, governmental agencies, public and private insurance companies, investor relations, capital funding, strategic planning and acquisitions and quality and lean production and operations. He started his career at Biomet and worked at Stryker, Smith & Nephew and Baxano Surgical where he held positions of increasing responsibility including CEO over the past ten years.
Reali also serves on the board of Ossio Integrative Orthopedics and on the board of AdvaMed. He previously served as Chairman of the Ethics and Compliance Committee for AdvaMed and as a board member of AdvaMed Accel.